Page last updated: 2024-09-04

ampelopsin and Myocardial Ischemia

ampelopsin has been researched along with Myocardial Ischemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ai, Q; Feng, K; Li, Y; Liu, S; Liu, X	1

Other Studies

1 other study(ies) available for ampelopsin and Myocardial Ischemia

Article	Year
The cardioprotective effect of dihydromyricetin prevents ischemia-reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways. Apoptosis : an international journal on programmed cell death, 2016, Volume: 21, Issue:12 Topics: Animals; Apoptosis; Cardiotonic Agents; Flavonols; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction	2016

Article

Year

The cardioprotective effect of dihydromyricetin prevents ischemia-reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways.

Apoptosis : an international journal on programmed cell death, 2016, Volume: 21, Issue:12

Topics: Animals; Apoptosis; Cardiotonic Agents; Flavonols; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction

2016